Can a tiny device suction out dangerous blood clots?

NCT ID NCT07749820

Recruiting now Disease control Sponsor: BrosMed Medical Co., Ltd Source: ClinicalTrials.gov ↗

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial is testing a device designed to remove blood clots from the deep veins of the legs, a condition called deep vein thrombosis (DVT). The study will enroll about 167 adults with acute or subacute DVT to see if the device can safely and effectively clear the blockage. Participants will be followed for six months to monitor their recovery and any potential complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Peripheral thrombectomy system (a device to remove blood clots from veins)
What this could lead to: If successful, this device could offer a minimally invasive way to clear DVT clots, potentially reducing pain, swelling, and the risk of long-term complications.
What could go wrong: This is an early-stage trial, so the device may not work as well as hoped or could have risks like bleeding, infection, or damage to the vein. More research is needed to confirm its safety and effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS (DVT) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

venous thromboembolism Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEEP VEIN THROMBOSIS (DVT)

Contacts and locations

Locations

Zhongshan Hospital, Fudan University
RECRUITING

Shanghai, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.